two new biotech drugs for colorectal cancer
You'll see two new biotech drugs for colorectal cancer, Avastin and Erbitux.
Avastin (bevacizumab) is the first angiogenesis inhibitor approved by the FDA. It works by slowing the growth of new blood vessels that tumors need to grow.
It's approved for metastatic colorectal cancer...in combination with traditional chemotherapy.